|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Rubella IgM ELISA | Androstenedione ELISA Assay | ANGPTL8 ELISA | Anti-Ustekinumab (Stelara®) ELISA | DPP4 / CD26 ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB19211 | IB79119 | 27795 | TM09036 | 27789 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of IgM antibody to Rubella in human serum or plasma. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme-linked immunosorbent assay (ELISA) for the determination of Androstenedione in serum and EDTA plasma. FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of Human ANGPTL8 ELISA in serum, EDTA plasma and cell culture supernatant. For research use only, not for use in diagnostic procedure | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of DPP4 / CD26 in human serum, EDTA-plasma, urine, and CSF. For research use only, not for use in diagnostic procedures. |
| Detection Target | Rubella IgM | 1,3,5(10)-estratriene-3,17ß-diol; 17ß-estradiol; E2. | NSE | sAPP Total | Human T-Cadherin(30K, 130K) |
| Sample Type | Human serum or plasma. | Human serum or plasma (EDTA, lithium heparin, or citrate plasma). | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Human serum and EDTA-plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | Calibrator used to calculate antibody index value used for interpretation of results. | 0.1 to 10.0 ng/mL | 0 / 0.61 - 80 pmol/L | Anti-Ustekinumab (Stelara®) | 125 to 8000 pg/mL |
| Sensitivity | Inquire | 10.6 pg/mL | Inquire | 0.06 ng/mL | 0.005 ng/mL |
| Assay Time | 20 min. incubation (RT) + 20 min. (RT) + 10 min. (RT) = 50 min. total incubation time. | 1 hr 30 mins (incubation) | 2 hours total incubation time. | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |